Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy

Important advances in diabetic retinopathy (DR) research and management have occurred in the last few years. Neurodegenerative changes before the onset of microvascular alterations have been well established. So, new strategies are required for earlier and more effective treatment of DR, which still...

Full description

Bibliographic Details
Main Authors: Sofia Perisset, M. Constanza Potilinski, Juan E. Gallo
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/18/13947
_version_ 1797579778832728064
author Sofia Perisset
M. Constanza Potilinski
Juan E. Gallo
author_facet Sofia Perisset
M. Constanza Potilinski
Juan E. Gallo
author_sort Sofia Perisset
collection DOAJ
description Important advances in diabetic retinopathy (DR) research and management have occurred in the last few years. Neurodegenerative changes before the onset of microvascular alterations have been well established. So, new strategies are required for earlier and more effective treatment of DR, which still is the first cause of blindness in working age. We describe herein gene regulation through Lnc-RNAs as an interesting subject related to DR. Long non-coding RNAs (Lnc-RNAs) are non-protein-coding transcripts larger than 200 nucleotides. Lnc-RNAs regulate gene expression and protein formation at the epigenetic, transcriptional, and translational levels and can impact cell proliferation, apoptosis, immune response, and oxidative stress. These changes are known to take part in the mechanism of DR. Recent investigations pointed out that Lnc-RNAs might play a role in retinopathy development as Metastasis-Associated Lung Adenocarcinoma Transcript (Lnc-MALAT1), Maternally expressed gene 3 (Lnc-MEG3), myocardial-infarction-associated transcript (Lnc-MIAT), Lnc-RNA H19, Lnc-RNA HOTAIR, Lnc-RNA ANRIL B-Raf proto-oncogene (Lnc-RNA BANCR), small nucleolar RNA host gene 16 (Lnc-RNA SNHG16) and others. Several molecular pathways are impacted. Some of them play a role in DR pathophysiology, including the PI3K-Akt signaling axis, NAD-dependent deacetylase sirtuin-1 (Sirti1), p38 mitogen-activated protein kinase (P38/mapk), transforming growth factor beta signaling (TGF-β) and nuclear factor erythroid 2-related factor 2 (Nrf2). The way Lnc-RNAs affect diabetic retinopathy is a question of great relevance. Performing a more in-depth analysis seems to be crucial for researchers if they want to target Lnc-RNAs. New knowledge on gene regulation and biomarkers will enable investigators to develop more specialized therapies for diabetic retinopathy, particularly in the current growing context of precision medicine.
first_indexed 2024-03-10T22:40:49Z
format Article
id doaj.art-fae44e9a77284130b9782a1c43eefdb7
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T22:40:49Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-fae44e9a77284130b9782a1c43eefdb72023-11-19T11:05:34ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-09-0124181394710.3390/ijms241813947Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic RetinopathySofia Perisset0M. Constanza Potilinski1Juan E. Gallo2Instituto de Investigaciones en Medicina Traslacional (IIMT), Facultad de Ciencias Biomédicas, Universidad Austral—CONICET, Pilar B1629, Buenos Aires, ArgentinaInstituto de Investigaciones en Medicina Traslacional (IIMT), Facultad de Ciencias Biomédicas, Universidad Austral—CONICET, Pilar B1629, Buenos Aires, ArgentinaInstituto de Investigaciones en Medicina Traslacional (IIMT), Facultad de Ciencias Biomédicas, Universidad Austral—CONICET, Pilar B1629, Buenos Aires, ArgentinaImportant advances in diabetic retinopathy (DR) research and management have occurred in the last few years. Neurodegenerative changes before the onset of microvascular alterations have been well established. So, new strategies are required for earlier and more effective treatment of DR, which still is the first cause of blindness in working age. We describe herein gene regulation through Lnc-RNAs as an interesting subject related to DR. Long non-coding RNAs (Lnc-RNAs) are non-protein-coding transcripts larger than 200 nucleotides. Lnc-RNAs regulate gene expression and protein formation at the epigenetic, transcriptional, and translational levels and can impact cell proliferation, apoptosis, immune response, and oxidative stress. These changes are known to take part in the mechanism of DR. Recent investigations pointed out that Lnc-RNAs might play a role in retinopathy development as Metastasis-Associated Lung Adenocarcinoma Transcript (Lnc-MALAT1), Maternally expressed gene 3 (Lnc-MEG3), myocardial-infarction-associated transcript (Lnc-MIAT), Lnc-RNA H19, Lnc-RNA HOTAIR, Lnc-RNA ANRIL B-Raf proto-oncogene (Lnc-RNA BANCR), small nucleolar RNA host gene 16 (Lnc-RNA SNHG16) and others. Several molecular pathways are impacted. Some of them play a role in DR pathophysiology, including the PI3K-Akt signaling axis, NAD-dependent deacetylase sirtuin-1 (Sirti1), p38 mitogen-activated protein kinase (P38/mapk), transforming growth factor beta signaling (TGF-β) and nuclear factor erythroid 2-related factor 2 (Nrf2). The way Lnc-RNAs affect diabetic retinopathy is a question of great relevance. Performing a more in-depth analysis seems to be crucial for researchers if they want to target Lnc-RNAs. New knowledge on gene regulation and biomarkers will enable investigators to develop more specialized therapies for diabetic retinopathy, particularly in the current growing context of precision medicine.https://www.mdpi.com/1422-0067/24/18/13947Lnc-RNAsdiabetic retinopathyblindnessgenomicsgene therapyretina
spellingShingle Sofia Perisset
M. Constanza Potilinski
Juan E. Gallo
Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy
International Journal of Molecular Sciences
Lnc-RNAs
diabetic retinopathy
blindness
genomics
gene therapy
retina
title Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy
title_full Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy
title_fullStr Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy
title_full_unstemmed Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy
title_short Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy
title_sort role of lnc rnas in the pathogenesis and development of diabetic retinopathy
topic Lnc-RNAs
diabetic retinopathy
blindness
genomics
gene therapy
retina
url https://www.mdpi.com/1422-0067/24/18/13947
work_keys_str_mv AT sofiaperisset roleoflncrnasinthepathogenesisanddevelopmentofdiabeticretinopathy
AT mconstanzapotilinski roleoflncrnasinthepathogenesisanddevelopmentofdiabeticretinopathy
AT juanegallo roleoflncrnasinthepathogenesisanddevelopmentofdiabeticretinopathy